MVision AI obtains a new CE mark: Ultimate segmentation service now with lymph nodes

Less than a year after the CE marking of MVision Segmentation Service 1.1, our team has obtained another one: The state-of-the-art solution is now also available with lymph nodes. With the ability to contour lymph nodes, we enter an era where AI algorithms actually help clinicians in every contouring step of treatment planning.

Our algorithms accurately follow guidelines with lymph nodes making it efficient for clinicians to select the lymph levels to be treated and combine them in their treatment planning system. After reviewing, clinicians can simply apply a margin to create the planning target volume”, explains MVision AI CPO Jarkko Niemelä.

There are approximately 500-600 lymph nodes in a human body. Until now, clinicians have drawn lymph nodes with all lymph levels by hand. Going back and forth drawing and checking dozens of glands in one region, this method can take hours to complete. The risk for inter-observer variation is also high. 

MVision AI Segmentation Service 1.2 produces accurate auto-segmentation of lymph nodes for the pelvis, breast as well as head and neck in minutes. The system is trained to rigorously follow official guidelines. For the male pelvis, there are also two different versions available: pivotal and RTOG. A full list of guidelines in use can be found here. 

Lymph Nodes with Segmentation Service 1.2

The test use of the update has shown tremendous results. A recent study also supports its impact particularly in terms of decreased inter-observer variation with increased efficiency.

“The lymph node release indeed marks a new era, and I am extremely proud of our team for making it happen especially in the middle of the current circumstances“, concludes founder & CEO Mahmudul Hasan


Would you like to see the new update in action? Let us know and we’ll get back to you.

Our Newsletter

Subscribe to get information, latest news and other interesting offers about MVision AI

Related Posts

2.7.2024

Breaking New Ground: MVision AI Contour+ for Upright MRI Scans

Results on testing MVision AI Contour+ for an ingenious and modern approach in radiation therapy have been recently presented at the 62nd Particle Therapy Co-Operative Group (PTCOG) conference in Singapore. Despite being trained using supine MR data and a different magnetic strength from different scanners, authors reported that MVision AI's…

Articles

28.6.2024

AI Role in Improving Contouring Skills of Radiation Oncologists—Results From a Large International Project

Many regions of the globe face significant disparities between the need of radiation therapy and its availability [1]. Another challenge is providing adequate training for radiation oncology professionals [2]. The cancer burden is expected to rise everywhere, especially the low- and middle-income countries [3]. Artificial intelligence offers a wide range…

Articles

20.6.2024

World Kidney Cancer Day 2024: “Listen”

World Kidney Cancer Day is observed every year on the second Thursday of June. “Listening” is this year’s theme, which refers to the benefits of shared decision making, patient’s empowerment to seek a second opinion and creating awareness around misinformation and how to check if sources are reliable (1). More…

News